Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...
Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...
Indianapolis-based Eli Lilly and Co. reported fourth-quarter ... about reaching the limits of the obesity market and that Lilly’s manufacturing expansion may be too aggressive.
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
(AP) — Lilly ... to increase manufacturing should lead to ongoing, solid growth for the drugs, Edward Jones analyst John Boylan said in a research note. For 2025, the Indianapolis drugmaker ...
(Reuters) -Eli Lilly on Thursday ... but has been subdued since October when Lilly reported disappointing sales for its highly in-demand treatments. The Indianapolis-based drugmaker reported ...
Diabetes and Obesity Drugs Fuel Eli Lilly ... manufacturing should lead to ongoing, solid growth for the drugs, Edward Jones analyst John Boylan said in a research note. For 2025, the Indianapolis ...
Eli Lilly LLY-N on Thursday ... but has been subdued since October when Lilly reported disappointing sales for its highly in-demand treatments. The Indianapolis-based drugmaker reported sales ...